Business Context and Reporting Period
Company: Nanophase Technologies Corporation (Note: Request metadata listed "SOLESENCE, INC." but the filing text identifies the registrant as Nanophase Technologies Corporation).
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: Nanophase is a nanomaterials developer and commercial manufacturer producing engineered nanomaterials for markets including sunscreens, architectural coatings, industrial coatings, personal care, and semiconductor polishing (CMP). The company operates as a single business segment with all long-lived assets located in the United States.
Key Financial Metrics
| Metric | Q1 2008 | Q1 2007 |
|---|---|---|
| Total Revenue | $3,054,108 | $2,906,437 |
| Gross Profit | $1,053,900 | $713,162 |
| Gross Margin | 34.5% | 24.5% |
| Net Loss | $(947,827) | $(1,224,027) |
| Loss Per Share (Basic/Diluted) | $(0.04) | $(0.06) |
| Cash and Cash Equivalents | $1,234,033 | $967,731 |
| Total Investments | $14,808,624 | $16,145,844 |
| Total Current Assets | $19,528,950 | $19,495,953 |
| Total Current Liabilities | $2,433,533 | $1,993,334 |
| Long-Term Debt (net) | $1,526,524 | $1,512,507 |
| Net Cash Used in Operating Activities | $(574,141) | $(921,420) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 5.1% year-over-year, driven by a 5.3% increase in product revenue. Growth was attributed to increased sales in architectural coatings and to Rohm and Haas Electronic Materials, partially offset by decreased sales to the largest customer and BYK-Chemie.
- Margin Expansion: Gross profit increased 47.8% to $1.05 million. Gross margin improved from 24.5% to 34.5% due to decreased commodity metal pricing, reduced manufacturing overhead, and favorable product mix.
- Expense Management:
- Cost of Revenue: Decreased 8.8% to $2.0 million.
- R&D Expense: Decreased 16.3% to $438,695, primarily due to reductions in salary, outside testing, and stock compensation.
- SG&A Expense: Increased 20.1% to $1.69 million. This increase was driven by patent and trademark write-offs (approx. $131,000 related to a patent re-examination cancellation) and higher audit/legal fees.
- Liquidity: Cash and cash equivalents increased by $670,958 during the quarter. Total liquid assets (cash + investments) stood at approximately $16.0 million.
Guidance, Outlook, Risks, and Contingencies
- Outlook: Management expects growth in end-user adoption in 2008 and beyond, particularly in CMP and fine polishing markets. Capital spending for 2008 is expected to be approximately $700,000 but could be higher depending on customer demand.
- Customer Concentration Risk: Three customers accounted for approximately 79% of total revenue in Q1 2008 (37%, 32%, and 10%).
- Contractual Contingencies (BASF): The supply agreement with BASF (the largest customer) contains financial covenants. A "triggering event" requiring technology transfer and/or equipment sale to BASF occurs if:
- Annual earnings are negative AND cash/investments are less than $2.0 million.
- Debt maturity acceleration occurs for principal >$10 million.
- The company becomes insolvent.
Management believes current liquidity (~$16 million) avoids the first trigger for the foreseeable future.
- Patent Litigation: The USPTO cancelled all claims in US Patent No. 6,669,823 B1 (NanoArc Synthesis) in February 2008. The company wrote off approximately $131,000 related to this patent but maintains pending continuation and divisional applications.
- Investment Liquidity: The company holds $6 million in Auction Rate Securities (ARS) that have experienced "failed auctions." While these are AAA-rated and guaranteed by the Department of Education, liquidity may be constrained until auctions succeed.
Investor Verification Checklist
- Liquidity vs. Covenants: Verify that cash and investment balances remain well above the $2.0 million threshold required to avoid triggering the BASF supply agreement covenants.
- ARS Liquidity: Monitor the status of the $6 million in Auction Rate Securities and the potential impact of continued failed auctions on short-term liquidity needs.
- Customer Concentration: Assess the stability of revenue from the top three customers, which represent nearly 80% of total sales.
- Patent Portfolio: Review the status of the pending continuation and divisional patent applications following the cancellation of the primary NanoArc patent claims.
- Capital Requirements: Confirm if the projected $700,000 capital spend is sufficient or if unplanned growth or equipment replacement (due to potential covenant triggers) will require additional financing.